Aztreonam, ceftriaxone, moxalactam, cefotaxime, cefsulodin, cefoperazone, piperacillin, azlocillin, carbenicillin, amikacin, gentamicin, tobramycin, sisomicin and dibekacin were tested by broth dilution against 161 isolates of Pseudomonas aeruginosa. Seventy-one of these strains were selected for their resistance to carbenicillin and aminoglycosides and classified as 'multiply resistant' strains. Over all, aztreonam showed the greatest antipseudomonal activity by far, followed by ceftriaxone, moxalactam, cefotaxime and amikacin. Piperacillin, azlocillin, cefsulodin, and cefoperazone were highly active against carbenicillin and/or aminoglycoside-susceptible P. aeruginosa strains, but were also poorly inhibitory against multiply resistant iso...
We have measured the in-vitro activity of 27 antimicrobials against 211 clinical and ten reference s...
The in vitro activity of meropenem was compared with those of six other antimicrobials against up to...
The activity of ceftazidime-avibactam was compared with that of ceftazidime alone and meropenem agai...
Combination therapy has been recommended to treat Pseudomonas aeruginosa infections worldwide. The p...
The in vitro activities of imipenem, aztreonam, piperacillin, ciprofloxacin and amikacin were tested...
minocycline, against 120 isolates of Pseudomonas aeruginosa was examined. In addition, the efficacy ...
The efficacy of ceftazidime, piperacillin, tobramycin and ticarcillin was tested in vitro against 10...
Jn-vitro activity of ceftazidime was compared with five other recently developed cephalosporins: ccf...
Azlocillin was more active in vitro than ticarcillin or carbenicillin against 561 aminoglycoside-res...
As the threat brought forth by the prevalence of multiple antibiotic resistance of bacteria increase...
Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics again...
Abstract Background There are limited choice of antimicrobial agents to treat infection with metallo...
<p>The antibacterial in vitro activity of carumonam, a new monobactam, and cefpirome, a new ce...
In vitro activity of aztreonam was compared with that of ceftazidime, cefotaxime, cefoperazone, pipe...
The antibacterial activity of aztreonam (AZT), a newly developed monobactam, against a total of 637 ...
We have measured the in-vitro activity of 27 antimicrobials against 211 clinical and ten reference s...
The in vitro activity of meropenem was compared with those of six other antimicrobials against up to...
The activity of ceftazidime-avibactam was compared with that of ceftazidime alone and meropenem agai...
Combination therapy has been recommended to treat Pseudomonas aeruginosa infections worldwide. The p...
The in vitro activities of imipenem, aztreonam, piperacillin, ciprofloxacin and amikacin were tested...
minocycline, against 120 isolates of Pseudomonas aeruginosa was examined. In addition, the efficacy ...
The efficacy of ceftazidime, piperacillin, tobramycin and ticarcillin was tested in vitro against 10...
Jn-vitro activity of ceftazidime was compared with five other recently developed cephalosporins: ccf...
Azlocillin was more active in vitro than ticarcillin or carbenicillin against 561 aminoglycoside-res...
As the threat brought forth by the prevalence of multiple antibiotic resistance of bacteria increase...
Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics again...
Abstract Background There are limited choice of antimicrobial agents to treat infection with metallo...
<p>The antibacterial in vitro activity of carumonam, a new monobactam, and cefpirome, a new ce...
In vitro activity of aztreonam was compared with that of ceftazidime, cefotaxime, cefoperazone, pipe...
The antibacterial activity of aztreonam (AZT), a newly developed monobactam, against a total of 637 ...
We have measured the in-vitro activity of 27 antimicrobials against 211 clinical and ten reference s...
The in vitro activity of meropenem was compared with those of six other antimicrobials against up to...
The activity of ceftazidime-avibactam was compared with that of ceftazidime alone and meropenem agai...